Altered Colonic Mucosal Polyunsaturated Fatty Acid (PUFA) Derived Lipid Mediators in Ulcerative Colitis: New Insight into Relationship with Disease Activity and Pathophysiology

Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis

(2013) Ashwin N. Ananthakrishnan   ANNALS OF INTERNAL MEDICINE

Review article: remission rates achievable by current therapies for inflammatory bowel disease

(2011) L. Peyrin-Biroulet et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Biological and histological parameters as predictors of relapse in ulcerative colitis: A prospective study

(2011) Sheenam Azad et al.   Saudi Journal of Gastroenterology

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?

(2010) Geert R D'Haens et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Comprehensive Lipidomics Analysis of Bioactive Lipids in Complex Regulatory Networks

(2010) Mojgan Masoodi et al.   ANALYTICAL CHEMISTRY

A pro-resolution mediator, prostaglandin D2, is specifically up-regulated in individuals in long-term remission from ulcerative colitis

(2010) L. Vong et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Review: Current trends in inflammatory bowel disease: the natural history

(2010) Ebbe Langholz   Therapeutic Advances in Gastroenterology

Multilevel Data Analysis of a Crossover Designed Human Nutritional Intervention Study

(2008) Ewoud J. J. van Velzen et al.   JOURNAL OF PROTEOME RESEARCH

Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases

(2008) Philip C. Calder   MOLECULAR NUTRITION & FOOD RESEARCH